A one-pot synthesis and biological activity of ageladine A and analogues

Sudhir R. Shengule, Wendy L. Loa-Kum-Cheung, Christopher R. Parish, Mélina Blairvacq, Laurent Meijer, Youichi Nakao, Peter Karuso

    Research output: Contribution to journalArticle

    19 Citations (Scopus)

    Abstract

    A one-pot synthesis of ageladine A and analogues is reported. The key Pictet-Spengler reaction between 2-aminohistamine and aryl aldehydes has been successfully utilized for the synthesis of the natural product and 14 analogues. These compounds were screened for their matrix metalloprotease (MMP) and kinase inhibition to develop the first structure-activity relationship of ageladine A analogues. One compound, which showed significant kinase activity but little MMP inhibitory activity, was found to be highly active in an antiangiogenic screen, suggesting that the angiogenic activity of ageladine A is not associated with MMP inhibition but rather kinase inhibitory activity. Cytotoxicity was excluded as a mode of action by the assay of ageladine A and an analogue against 60 human cell lines.

    Original languageEnglish
    Pages (from-to)2492-2503
    Number of pages12
    JournalJournal of Medicinal Chemistry
    Volume54
    Issue number7
    DOIs
    Publication statusPublished - 2011 Apr 14

    Fingerprint

    Metalloproteases
    Phosphotransferases
    Structure-Activity Relationship
    Biological Products
    Aldehydes
    Cell Line
    Ageladine A

    ASJC Scopus subject areas

    • Molecular Medicine
    • Drug Discovery

    Cite this

    Shengule, S. R., Loa-Kum-Cheung, W. L., Parish, C. R., Blairvacq, M., Meijer, L., Nakao, Y., & Karuso, P. (2011). A one-pot synthesis and biological activity of ageladine A and analogues. Journal of Medicinal Chemistry, 54(7), 2492-2503. https://doi.org/10.1021/jm200039m

    A one-pot synthesis and biological activity of ageladine A and analogues. / Shengule, Sudhir R.; Loa-Kum-Cheung, Wendy L.; Parish, Christopher R.; Blairvacq, Mélina; Meijer, Laurent; Nakao, Youichi; Karuso, Peter.

    In: Journal of Medicinal Chemistry, Vol. 54, No. 7, 14.04.2011, p. 2492-2503.

    Research output: Contribution to journalArticle

    Shengule, SR, Loa-Kum-Cheung, WL, Parish, CR, Blairvacq, M, Meijer, L, Nakao, Y & Karuso, P 2011, 'A one-pot synthesis and biological activity of ageladine A and analogues', Journal of Medicinal Chemistry, vol. 54, no. 7, pp. 2492-2503. https://doi.org/10.1021/jm200039m
    Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y et al. A one-pot synthesis and biological activity of ageladine A and analogues. Journal of Medicinal Chemistry. 2011 Apr 14;54(7):2492-2503. https://doi.org/10.1021/jm200039m
    Shengule, Sudhir R. ; Loa-Kum-Cheung, Wendy L. ; Parish, Christopher R. ; Blairvacq, Mélina ; Meijer, Laurent ; Nakao, Youichi ; Karuso, Peter. / A one-pot synthesis and biological activity of ageladine A and analogues. In: Journal of Medicinal Chemistry. 2011 ; Vol. 54, No. 7. pp. 2492-2503.
    @article{86de25513b14457ea929880eda6d63fa,
    title = "A one-pot synthesis and biological activity of ageladine A and analogues",
    abstract = "A one-pot synthesis of ageladine A and analogues is reported. The key Pictet-Spengler reaction between 2-aminohistamine and aryl aldehydes has been successfully utilized for the synthesis of the natural product and 14 analogues. These compounds were screened for their matrix metalloprotease (MMP) and kinase inhibition to develop the first structure-activity relationship of ageladine A analogues. One compound, which showed significant kinase activity but little MMP inhibitory activity, was found to be highly active in an antiangiogenic screen, suggesting that the angiogenic activity of ageladine A is not associated with MMP inhibition but rather kinase inhibitory activity. Cytotoxicity was excluded as a mode of action by the assay of ageladine A and an analogue against 60 human cell lines.",
    author = "Shengule, {Sudhir R.} and Loa-Kum-Cheung, {Wendy L.} and Parish, {Christopher R.} and M{\'e}lina Blairvacq and Laurent Meijer and Youichi Nakao and Peter Karuso",
    year = "2011",
    month = "4",
    day = "14",
    doi = "10.1021/jm200039m",
    language = "English",
    volume = "54",
    pages = "2492--2503",
    journal = "Journal of Medicinal Chemistry",
    issn = "0022-2623",
    publisher = "American Chemical Society",
    number = "7",

    }

    TY - JOUR

    T1 - A one-pot synthesis and biological activity of ageladine A and analogues

    AU - Shengule, Sudhir R.

    AU - Loa-Kum-Cheung, Wendy L.

    AU - Parish, Christopher R.

    AU - Blairvacq, Mélina

    AU - Meijer, Laurent

    AU - Nakao, Youichi

    AU - Karuso, Peter

    PY - 2011/4/14

    Y1 - 2011/4/14

    N2 - A one-pot synthesis of ageladine A and analogues is reported. The key Pictet-Spengler reaction between 2-aminohistamine and aryl aldehydes has been successfully utilized for the synthesis of the natural product and 14 analogues. These compounds were screened for their matrix metalloprotease (MMP) and kinase inhibition to develop the first structure-activity relationship of ageladine A analogues. One compound, which showed significant kinase activity but little MMP inhibitory activity, was found to be highly active in an antiangiogenic screen, suggesting that the angiogenic activity of ageladine A is not associated with MMP inhibition but rather kinase inhibitory activity. Cytotoxicity was excluded as a mode of action by the assay of ageladine A and an analogue against 60 human cell lines.

    AB - A one-pot synthesis of ageladine A and analogues is reported. The key Pictet-Spengler reaction between 2-aminohistamine and aryl aldehydes has been successfully utilized for the synthesis of the natural product and 14 analogues. These compounds were screened for their matrix metalloprotease (MMP) and kinase inhibition to develop the first structure-activity relationship of ageladine A analogues. One compound, which showed significant kinase activity but little MMP inhibitory activity, was found to be highly active in an antiangiogenic screen, suggesting that the angiogenic activity of ageladine A is not associated with MMP inhibition but rather kinase inhibitory activity. Cytotoxicity was excluded as a mode of action by the assay of ageladine A and an analogue against 60 human cell lines.

    UR - http://www.scopus.com/inward/record.url?scp=79953767989&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=79953767989&partnerID=8YFLogxK

    U2 - 10.1021/jm200039m

    DO - 10.1021/jm200039m

    M3 - Article

    C2 - 21413800

    AN - SCOPUS:79953767989

    VL - 54

    SP - 2492

    EP - 2503

    JO - Journal of Medicinal Chemistry

    JF - Journal of Medicinal Chemistry

    SN - 0022-2623

    IS - 7

    ER -